Suspension of trading

Business Segments Durect

Stocks

DRRX

US2666055007

Delayed Nasdaq Other stock markets 16:00:00 2025-09-10 EDT			5-day change	1st Jan Change
1.910 ^USD	-1.04%		-.--%	-

25-09-11	Bausch Health Companies Inc. completed the acquisition of DURECT Corporation.	CI
25-09-11	Bausch Health Completes US$63 Million Durect Acquisition, Adds Breakthrough Hepatitis Therapy to Pipeline	MT

Sales 2024 by Business Segment

© MarketScreener.com See more

Sales 2024 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Pharmaceutical Products
Research, Development and Manufacturing of Pharmaceutical Products						30.11M	13.98M	19.28M	8.55M	2.03M
Total Assets						75.64M	91.99M	60.1M	45.19M	18.35M
Interest Expense						-2.24M	-2.15M	-2.4M	-2.79M	-
Income Tax Expense						-	-	-	-	-
CAPEX						-208K	-194K	-111K	-52K	-
EBT						-14.34M	-36.26M	-35.33M	-27.62M	-18.41M
D&A						297K	288K	119K	31K	84K
Operating Income						-12.62M	-34.27M	-35.08M	-36.88M	-18.91M
Net Income						-582K	-36.26M	-35.33M	-27.62M	-8.32M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Europe						1.39M	6.63M	11.79M	2.3M	1.59M
Others						657K	642K	557K	1.07M	250K
United States						26.89M	5.69M	5.45M	4.62M	189K
Japan						1.17M	1.02M	1.49M	559K	-

-40%: Exceptional extension

SEIZE THE OFFER!